APEX Orthopedics Investments has been established as an asset management company dedicated to fostering innovation and device development in the foot and ankle orthopedic sector.
The founding group brings over four decades of collective experience in successful product development, having launched 200+ products, generating a cumulative revenue of USD $3 billion.
Focused on investing in and incubating Class II and Class III devices, APEX Orthopedics Investments is committed to driving novel solutions in fixation hardware, midfoot arthrodesis, midfoot arthroplasty and Achilles tendon. The company currently boasts 12 pending patents in the United States and internationally, along with 73 invention disclosures.
APEX Orthopedics Investments has organized its intellectual property into four distinct portfolio companies, each focused on addressing critical needs within the field. These portfolio companies are poised to drive significant advancements and improvements in orthopedic care.
- Medifuse Ortho, Plating and Screw Systems
- Innovative Midfoot Solutions, Midfoot Arthrodesis
- Pharus Ortho, Minimally Invasive Achilles Tendon Repair
- Extrados Ortho, Midfoot Arthroplasty
“Our mission at APEX Orthopedics Investments is to catalyze innovation within the foot and ankle orthopedic industry,” stated Chris Banas, CEO and President of APEX Orthopedics Investments. “Through strategic investments and incubation, we aim to revolutionize patient care and outcomes while empowering orthopedic professionals with cutting-edge solutions.”
Source: APEX Orthopedics Investments
APEX Orthopedics Investments has been established as an asset management company dedicated to fostering innovation and device development in the foot and ankle orthopedic sector.
The founding group brings over four decades of collective experience in successful product development, having launched 200+ products, generating a cumulative revenue...
APEX Orthopedics Investments has been established as an asset management company dedicated to fostering innovation and device development in the foot and ankle orthopedic sector.
The founding group brings over four decades of collective experience in successful product development, having launched 200+ products, generating a cumulative revenue of USD $3 billion.
Focused on investing in and incubating Class II and Class III devices, APEX Orthopedics Investments is committed to driving novel solutions in fixation hardware, midfoot arthrodesis, midfoot arthroplasty and Achilles tendon. The company currently boasts 12 pending patents in the United States and internationally, along with 73 invention disclosures.
APEX Orthopedics Investments has organized its intellectual property into four distinct portfolio companies, each focused on addressing critical needs within the field. These portfolio companies are poised to drive significant advancements and improvements in orthopedic care.
- Medifuse Ortho, Plating and Screw Systems
- Innovative Midfoot Solutions, Midfoot Arthrodesis
- Pharus Ortho, Minimally Invasive Achilles Tendon Repair
- Extrados Ortho, Midfoot Arthroplasty
“Our mission at APEX Orthopedics Investments is to catalyze innovation within the foot and ankle orthopedic industry,” stated Chris Banas, CEO and President of APEX Orthopedics Investments. “Through strategic investments and incubation, we aim to revolutionize patient care and outcomes while empowering orthopedic professionals with cutting-edge solutions.”
Source: APEX Orthopedics Investments
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.